Evidence map›Paper›PMID 27815839›Full record

ArticleMolecular neurobiology2017

Disruption of Ninjurin1 Leads to Repetitive and Anxiety-Like Behaviors in Mice.

Hoang Le, Bum Ju Ahn, Hye Shin Lee, Anna Shin, Sujin Chae, Sung Yi Lee, Min Wook Shin, Eun-Ji Lee, Jong-Ho Cha, Taekwon Son and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. The role of NINJ1 in diseases.Cell death discovery · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. A guide to cell death pathways.Nature reviews. Molecular cell biology · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Hoang LeSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Bum Ju AhnSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Hye Shin LeeSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Anna ShinDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, South Korea.
Sujin ChaeKAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, South Korea.
Sung Yi LeeSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Min Wook ShinSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Eun-Ji LeeSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Jong-Ho ChaSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Taekwon SonSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Ji Hae SeoSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Hee-Jun WeeSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea.
Hyo-Jong LeeCollege of Pharmacy, Inje University, Gimhae, 621-749, South Korea.
Yongwoo JangDepartment of Psychiatry and Program in Neuroscience, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
Eng H LoNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02129, USA.
Sejin JeonDepartment of Life Sciences, Ewha Womans University, Seoul, 120-750, South Korea.
Goo Taeg OhDepartment of Life Sciences, Ewha Womans University, Seoul, 120-750, South Korea.
Daesoo KimDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 305-701, South Korea.
Kyu-Won KimSNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 151-742, South Korea. qwonkim@snu.ac.kr.
Seoul National University · KRHarvard University · USKorea Advanced Institute of Science and Technology · KREwha Womans University · KRInje University · KR

Funding

Biphasic mechanisms of injury and repair in stroke therapyR37NS037074 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI LO, ENG H. · 2008 to 2015
$3.2M
National Research Foundation of Korea 2011-0021874; 2013-036038; 2011-0030001; 2014K2A1C2074279National Research Foundation of Korea 2013003407National Research Foundation of Korea 2013R1A1A2058956National Research Foundation of Korea 2015R1C1A2A01054446NINDS NIH HHS R37-NS37074; R01-76694; P01-NS55104
6 · The paper itself

Abstract

Over the last few decades, molecular neurobiology has uncovered many genes whose deficiency in mice results in behavioral traits associated with human neuropsychiatric disorders such as autism, obsessive-compulsive disorder (OCD), and schizophrenia. However, the etiology of these common diseases remains enigmatic with the potential involvement of a battery of genes. Here, we report abnormal behavioral phenotypes of mice deficient in a cell adhesion molecule Ninjurin 1 (Ninj1), which are relevant to repetitive and anxiety behaviors of neuropsychiatric disorders. Ninj1 knockout (KO) mice exhibit compulsive grooming-induced hair loss and self-made lesions as well as increased anxiety-like behaviors. Histological analysis reveals that Ninj1 is predominantly expressed in cortico-thalamic circuits, and neuron-specific Ninj1 conditional KO mice manifest aberrant phenotypes similar to the global Ninj1 KO mice. Notably, the brains of Ninj1 KO mice display altered synaptic transmission in thalamic neurons as well as a reduced number of functional synapses. Moreover, the disruption of Ninj1 leads to glutamatergic abnormalities, including increased ionotropic glutamate receptors but reduced glutamate levels. Furthermore, chronic treatment with fluoxetine, a drug reportedly ameliorates compulsive behaviors in mice, prevents progression of hair loss and alleviates the compulsive grooming and anxiety-like behavior of Ninj1 KO mice. Collectively, our results suggest that Ninj1 could be involved in neuropsychiatric disorders associated with impairments of repetitive and anxiety behaviors.

Indexed as

AnimalsAnxietyCell Adhesion Molecules, NeuronalCells, CulturedCompulsive BehaviorMaleMiceMice, Inbred C57BLMice, KnockoutNerve Growth FactorsCell Adhesion Molecules, NeuronalNerve Growth FactorsNinj1 protein, mouseAnxiety-like behaviorFluoxetineGlutamate receptorsNinj1OCDRepetitive behavior

Identifiers

PMID27815839
OpenAlexW2548317364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.